<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=2179646889074564&amp;ev=PageView&amp;noscript=1">

Innovating at the speed of AI

The world has undergone a rapid and transformative shift since the adoption of AI. This is particularly evident in biopharma, where the possibility of a truly ground-breaking solution that accelerates research, disease diagnosis and trial-matching is at hand.

We’ve assembled an exceptional team to do just that, comprised of individuals with an indisputable track record of excellence.

Our quest is backed by savvy investors who support our vision of GenAI applications for the Pharma sector.

Meet the team

Ryght | Simon Arkell

Simon Arkell

Co-Founder and CEO
Simon is a hi tech entrepreneur and investor with a focus on AI and healthcare technology. Co-founder of 7 venture backed companies, including Deep Lens, Predixion Software and Versifi, which together raised over $100M in venture backing. All three were acquired.
Ryght | Alex Dickinson

Alex Dickinson

Co-Founder and Chairman
Co-founder/Chair/CEO: ChromaCode (COVID XPrize winner); Helixis (acquired by Illumina) and Luxtera (acquired by Cisco). Board member Gencove (low pass sequencing) and previously PRA Health Sciences (public, acquired by ICON). Seven year Illumina SVP (led BaseSpace and PopSeq businesses). Began career in research at Bell Labs; co-inventor of the CMOS fingerprint sensor.
Ryght | Johnny Crupi

Johnny Crupi

Co-Founder and CTO
Prior to co-founding Synthetica Bio, Johnny Crupi was CTO at Predixion and JackBe. Mr. Crupi brings three decades of experience building enterprise scale applications for real-time systems. He has been awarded as a Sun Microsystems Distinguished Engineer and is a three-time Washingtonian Tech Titan. Mr. Crupi has a M.S. in Engineering Administration with a sub-focus in AI from the George Washington University and a B.S. in Mechanical Engineering for the University of Maryland.
Ryght | Chadi Nabhan

Chadi Nabhan

Chief Medical Officer & Head of Strategy

Dr. Chadi Nabhan is the Chief Medical Officer and Head of Strategy at Ryght, bringing over 20 years of oncology and leadership experience to drive innovation and strategic vision.

His past roles include SVP and Chairman of the POA at Caris Life Sciences, VP and CMO at Cardinal Health Specialty Solutions, and EVP and CMO at Aptitude Health. Academically, he has served as an Associate Professor of Medicine and the Director of Outpatient Cancer Clinics at the University of Chicago, and before that, Chief of Oncology and Cancer Institute Medical Director at Advocate Lutheran General Hospital in Park Ridge, IL. Dr. Nabhan is an esteemed author, podcaster, and speaker, recognized for his contributions to medical oncology and clinical research. 

Ryght | Tyrone Richardson

Tyrone Richardson

Chief Commercial Officer
Formerly Vice President of Sales at Paradigm, Tyrone Richardson, brings his expertise in business development in sales of research services to Ryght.  Mr. Richardson held numerous sales leadership positions at Miraca Life Sciences, Caris Life Sciences, and Inform Diagnostics. and has invaluable career experience in AI/ML, data integration, diagnostics, genomics and clinical trials. Mr. Richardson received his M.B.A. Health Care Management from Marylhurst University and his B.S. in Business Administration from the University of Oregon.
Ryght | Alexi Polenur

Alexi Polenur

VP Engineering
An accomplished engineering executive with more than 20 years' experience in enterprise software development, business intelligence, AI real-time data processing, big data and cloud technologies, Alexi Polenur was most recently the Vice President of Engineering and AI at Graphene Edge (formerly Gravetti). Previously, he led architecture and engineering as Director IoT Edge AI and Analytics at Greenwave Systems Inc.; Director, IoT Engineering at Predixion Software, among other companies. Mr. Polenur holds an M.S. in Computer Science and a B.S. in Electrical Engineering, both from the National Technical University of Ukraine.
Ryght | Kirby Bloom

Kirby Bloom

VP Data & AI Engineering
Kirby Bloom has more than twenty years of experience developing large-scale data analytic platforms across the healthcare and life sciences industry. His most recent role was Chief Technology Officer at LunaDNA, an interactive platform that enables large-scale, continuous research for disease registries. Previous to this, he was Head of Software and Informatics for Applied Genomics at Illumina, building analytic platforms serving the forensics, transplant diagnostics, microbiology, custom sequencing and consumer markets. Kirby holds an M.S. in Data Science from the University of California, Berkeley and a B.S. in Management Information Systems for Texas Tech University.
Ryght | Sara Dada

Sara Dada

Product Manager
Sara Dada is a Product Manager based in the San Francisco Bay Area. She has previously served on the product team of a B2B SaaS company, consulted for various startups, and worked as a data analyst for a venture fund. She studied Business Administration and Technology Ethics at Cal Poly SLO.
Ryght | Emma Cushman

Emma Cushman

Sales & Marketing Associate
Emma Cushman is a Sales and Marketing Associate with Ryght. Emma supports sales, account management and project coordination. She received her Bachelor of Science in Marketing from the University of Tampa, and leverages a data-driven approach to crafting impactful marketing strategies.
Ryght | Sanjay John

Sanjay John

Lead AI Solutions Engineer
Sanjay has worked at the intersection of biology and engineering for most of his career.  He's built products to help solve problems in healthcare using the latest in technology, from winning UC Health Hack in 2017 for Blueprints For Life, to designing a novel orthosis to assist patients with Essential Tremor. He received his Bachelor’s Degree in Bioengineering and Master’s Degree in Electrical Engineering with a specialization in Machine Learning & Data Science at UC San Diego. Most recently, he was a Senior Software Engineer at LunaDNA.


Ryght's initial funding is supported by leading investors with a shared vision to improve healthcare by leveraging advances in AI technology. The initial round was led by Virtue with participation from AIX Ventures, Iaso Ventures, Page One Ventures, Top Harvest Capital, and additional strategic angel investors.


We understand that the foundation of transformative life sciences solutions rests on cutting-edge technology, robust security, and infinite scalability. To ensure our customers experience unparalleled success, we strategically partner with the industry’s leading technology and cloud service providers. Our meticulously selected network of partners empowers us to deliver secure, scalable, and cutting-edge AI-driven solutions tailored for the unique challenges of the life sciences sector. 

Ready to learn more?

Get in touch